| Healthcare Press Releases + Feed Topics Locations Industries DatesPremium Press Releases | Show All
By Crossroads4Hope A national leader in comprehensive, no-cost supportive cancer care celebrates a milestone - and sets its sights on reaching more individuals and families
|  | By CorporateAds First-cycle FDA review delivers one of the strongest signals yet that NRx's preservative-free ketamine opportunity may be entering its final stretch, while the company's broader neuropsychiatric pipeline continues to gain momentum.
|  | By CorporateAds Today's Commercial Expansion, Growing Enterprise Deployments and Accelerating Merger Timeline Position MBody AI $MBAI to Capitalize on the Rapidly Emerging Multi-Trillion-Dollar Embodied AI Revolution
|  | By CorporateAds Potential DARPA Award, FDA-Authorized Phase 2/3 Trial, Breakthrough Therapy NRX-101, and Robotic-Enabled TMS Platform Highlight Expanding Opportunities for NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP)
|  | By Cummings Graduate Institute Integrated Behavioral Health: Applying the Biodyne Model in Healthcare brings together more than 30 healthcare leaders to advance integrated care across clinical settings.
|  | By CorporateAds First Commercial Deployment of FDA-Cleared AI-Guided TMS Navigation System, Expanded FDA Pathway for NRX-101, and Growing Commercial Infrastructure Highlight Accelerating Momentum for NRx Pharmaceuticals (N A S D A Q: NRXP)
|  | By CorporateAds Cosmos Health Inc. (N A S D A Q: COSM): 18 Series Nutraceutical Expansion, Record Q1 Results, EIB Financing Initiative, AI-Powered Drug Development, And Strong Long-Term Financial Guidance Position Cosmos Health For Potential Multi-Year Expansion
|  | By CorporateAds Cosmos Health Inc. (N A S D A Q: COSM): Veterinary Expansion, Proprietary Healthcare Brands, AI-Powered Drug Development, Telehealth Growth, and Strong Financial Guidance Position Cosmos Health for Potential Multi-Year Expansion
| By HealthBook+ HealthBook+, the personalized care delivery solution that helps clinicians better understand and support their patients, today announced a strategic partnership with Safety Net Connect (SNC), a leading provider of advanced virtual care and closed-loop...
|  | By CorporateAds Expanding HOPE Therapeutics Network Positions NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP for Potential Breakout 2026 Growth
|
All Press Releases
By Crossroads4Hope A national leader in comprehensive, no-cost supportive cancer care celebrates a milestone - and sets its sights on reaching more individuals and families
| By FTS Cleanroom UAE-based turnkey cleanroom engineering firm marks 17+ years in business with 1,000+ delivered projects spanning pharmaceutical, healthcare, and industrial cleanroom facilities across the Gulf, MENA, and Africa.
| By Meditech Insights Patient Registry Software Market: Global Market Growth Study, Future Trends, Demands, and Top Players Data by Forecast to 2031
|  | By CorporateAds First-cycle FDA review delivers one of the strongest signals yet that NRx's preservative-free ketamine opportunity may be entering its final stretch, while the company's broader neuropsychiatric pipeline continues to gain momentum.
|  | By CorporateAds Today's Commercial Expansion, Growing Enterprise Deployments and Accelerating Merger Timeline Position MBody AI $MBAI to Capitalize on the Rapidly Emerging Multi-Trillion-Dollar Embodied AI Revolution
| By The Health Pals Company LLC Henry C. Service, J.D. brings legal, regulatory and redevelopment experience to a community healthcare model serving underserved rural and urban areas.
| By Clinaptis Advisors Report develops a reverse-solve valuation framework separating VK2735's subcutaneous valuation floor from the unresolved commercial opportunity of the oral obesity program.
| By AGS Health AGS Health® a leading provider of tech-first revenue cycle management (RCM) solutions serving healthcare providers across the U.S.
| By Dr. Heavenly for Georgia, LLC Physicians, Healthcare Experts, Insurance Professionals and Community Leaders to Discuss Practical Solutions to Improve Healthcare Access and Outcomes for Georgia Families
|  | By CorporateAds Potential DARPA Award, FDA-Authorized Phase 2/3 Trial, Breakthrough Therapy NRX-101, and Robotic-Enabled TMS Platform Highlight Expanding Opportunities for NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP)
| By Meditech Insights The Global Stem Cells Market is projected to grow at a CAGR of approximately 9–12% through 2031, driven by increasing investments in regenerative medicine, expanding stem cell research, and the growing demand for advanced therapies to treat chronic and...
| By PSIDispo Plasti Surge Industries Pvt. Ltd. (PSI Dispo), a trusted name in healthcare consumables and infection-control solutions, will take part in Medicall 2026, India's leading B2B medical equipment and healthcare exhibition, scheduled from 24th to 26th July...
| By List2u.com LLC The company says modern healthcare growth requires connected systems that improve visibility, trust and market access before the first appointment.
| By Logix Construction, LLC In today's business environment, sales leadership is no longer about managing salespeople. It is about building a predictable revenue engine. Says Jim Sayazdad
| By Logix Construction, LLC Industry Expert Jim Sayadzad Highlights Emerging Trends Reshaping Sales Operations, Accountability, and Revenue Growth
|  | By Cummings Graduate Institute Integrated Behavioral Health: Applying the Biodyne Model in Healthcare brings together more than 30 healthcare leaders to advance integrated care across clinical settings.
| By Meals on Wheels South Florida Support Will Expand Senior Services and Deepen Community Impact
| By Corvus Global Events Join healthcare leaders, pharma executives, providers, AI innovators, policymakers, health systems, and digital pioneers redefining healthcare delivery, patient outcomes, and intelligent systems.
|  | By CorporateAds First Commercial Deployment of FDA-Cleared AI-Guided TMS Navigation System, Expanded FDA Pathway for NRX-101, and Growing Commercial Infrastructure Highlight Accelerating Momentum for NRx Pharmaceuticals (N A S D A Q: NRXP)
| By Filos Health Laboratory Inc As healthcare barriers continue to affect millions of Americans, Filos Health is redefining patient access by bringing laboratory and diagnostic services directly to homes, workplaces, and communities nationwide.
| By Meditech Insights The demand for oligonucleotide-based therapies is accelerating as biotech and pharmaceutical companies advance innovations in antisense oligonucleotides (ASOs), siRNA, microRNA, aptamers, and other nucleic acid therapeutics.
| By ClaraWell Inc. Long-running ClaraWell initiative exploring how people experience communication, trust, support, and empathy throughout healthcare interactions.
| By Joseph M Corrigan A timely call to trust, dignity and humanity in american healthcare
| By Clear Healthcare Solutions Lawrence Thompson joined the CLEARly Beneficial Podcast with a set of proposals that are specific, documented, and ready to implement. The system does not need more diagnosis. It needs someone willing to pull the trigger.
| By Clear Healthcare Solutions Peter Hayes joined the CLEARly Beneficial Podcast to make the case that American healthcare does not lack solutions, but the will to implement them.
|  | By CorporateAds Cosmos Health Inc. (N A S D A Q: COSM): 18 Series Nutraceutical Expansion, Record Q1 Results, EIB Financing Initiative, AI-Powered Drug Development, And Strong Long-Term Financial Guidance Position Cosmos Health For Potential Multi-Year Expansion
|  | By CorporateAds Cosmos Health Inc. (N A S D A Q: COSM): Veterinary Expansion, Proprietary Healthcare Brands, AI-Powered Drug Development, Telehealth Growth, and Strong Financial Guidance Position Cosmos Health for Potential Multi-Year Expansion
| By HealthBook+ HealthBook+, the personalized care delivery solution that helps clinicians better understand and support their patients, today announced a strategic partnership with Safety Net Connect (SNC), a leading provider of advanced virtual care and closed-loop...
|  | By CorporateAds Expanding HOPE Therapeutics Network Positions NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP for Potential Breakout 2026 Growth
|  | By CorporateAds NRx Pharmaceuticals, Inc.Improved Financial Position, Commercial Ketamine Manufacturing, FDA Progress, and Expanding Neuroplastic Therapy Infrastructure Position $NRXP for a Potential Breakout Phase
| By EquipMedy EquipMedy® is simplifying MedTech procurement in India through an integrated digital platform that streamlines product discovery, vendor comparison, procurement, delivery, and support—making healthcare operations faster, smarter.
|
Page: 1 2 NextPage updated every 10 minutes
| |